CLINICAL IMPLICATIONS OF ENZYME-INDUCTION AND ENZYME-INHIBITION

被引：190

作者：

PARK, BK

BRECKENRIDGE, AM

机构：

来源：

CLINICAL PHARMACOKINETICS | 1981年 / 6卷 / 01期

关键词：

D O I：

10.2165/00003088-198106010-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 24

页数：24

共 177 条

[1] EVIDENCE FOR FUNCTION OF D-GLUCARIC ACID AS AN INDICATOR FOR DRUG INDUCED ENHANCED METABOLISM THROUGH GLUCURONIC ACID PATHWAY IN MAN [J].

AARTS, EM .

BIOCHEMICAL PHARMACOLOGY, 1965, 14 (03) :359-&

[2]

AARTS EM, 1971, LANCET, V1, P859

[3]

ACOCELLA G, 1978, PHARMACOL RES COMMUN, V10, P271

[4] KINETIC STUDIES ON RIFAMPICIN .1. SERUM CONCENTRATION ANALYSIS IN SUBJECTS TREATED WITH DIFFERENT ORAL DOSES OVER A PERIOD OF 2 WEEKS [J].

ACOCELLA, G ;

BARONI, GC ;

MARCHETTI, M ;

PAGANI, V ;

NICOLIS, FB .

CHEMOTHERAPY, 1971, 16 (06) :356-+

[5]

Acocella G, 1973, Tijdschr Gastroenterol, V16, P186

[6]

ANDERS MW, 1966, MOL PHARMACOL, V2, P341

[7]

ANTLITZ AM, 1968, CURR THER RES CLIN E, V10, P70

[8]

ARCOS JC, 1961, J BIOL CHEM, V236, P1291

[9]

ARNOLD K, 1970, CLIN PHARMACOL THER, V11, P121

[10] EFFECT OF RIFAMPICIN ON NORETHISTERONE PHARMACOKINETICS [J].

BACK, DJ ;

BRECKENRIDGE, AM ;

CRAWFORD, F ;

MACIVER, M ;

ORME, ML ;

PARK, BK ;

ROWE, PH ;

SMITH, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (03) :193-197

← 1 2 3 4 5 6 7 8 9 10 →